ONWARD Medical results for the third quarter of 2026 are scheduled for release on November 3, when the neurotechnology company will also host a webcast with a business update.

Key Takeaways

  • CEO Dave Marver will present the webcast at 2:00 p.m. CET, or 8:00 a.m. ET.
  • A replay and supporting materials will be available after the webcast.

ONWARD Medical results and webcast

The Netherlands-based company announced the schedule on October 27. It did not disclose its third-quarter financial figures in the announcement.

The webcast will include a comprehensive business update alongside the results. ONWARD said a replay and supporting materials will be available through its investor relations site.

The company’s products and listings

ONWARD develops therapies for people with spinal cord injuries and other movement disabilities. Its ARC-EX system is cleared for commercial sale in the United States and Europe.

The company is also developing ARC-IM, an investigational implantable system designed to address needs including blood pressure instability after spinal cord injury. ARC-IM is not available for commercial use.

ONWARD shares are listed on Euronext Paris, Brussels and Amsterdam under the ticker ONWD. Its US depositary receipts trade on OTCQX under ONWRY.

Read More News

More FinanceVelix news

Disclaimer

This FinanceVelix article provides general information, not personalized financial, investment, legal, or tax advice. Market prices, interest rates and economic conditions can change; investments carry a risk of loss. Facts reflect the material available when published and may change. Check important information independently and consult a qualified professional when needed. Mentioning an asset, company, or service is not an endorsement.